SCHEMBL1133402

SCHEMBL1133402

COC(=O)c1ccccc1CC[C@@H](SC(C)=O)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1133408 1.00 — —
SCHEMBL1133404 1.00 — —
SCHEMBL1133401 1.00 — —
SCHEMBL12526232 0.94 — —
SCHEMBL2543420 0.92 — —
SCHEMBL1132498 0.91 — —
SCHEMBL2547277 0.91 — —
SCHEMBL8790589 0.89 — —
SCHEMBL13878247 0.89 CYSLTR1 (0.60) —
SCHEMBL9206923 0.88 CYSLTR1 (0.56) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2686301-B1 MONTELUKAST INTERMEDIATE CAMPHORSULFONIC SALT LESVI LABORATORIOS SL (ES) 2014-12-31 — — EP disclosed
EP-2552892-A1 EFFICIENT SYNTHESIS FOR THE PREPARATION OF MONTELUKAST AND NOVEL CRYSTALLINE FORM OF INTERMEDIATES THEREIN KRKA, D.D., Novo Mesto (SI) 2013-02-06 — — EP disclosed
WO-2012123506-A1 MONTELUKAST INTERMEDIATE CAMPHORSULFONIC SALT LABORATORIOS LESVI, S.L. (ES) 2012-09-20 — — WO disclosed
US-20120184000-A1 KETOREDUCTASE POLYPEPTIDES FOR THE PRODUCTION OF (S,E)-METHYL 2-(3-(3-(2-(7-CHLOROQUINOLIN-2-YL)VINYL)PHENYL)-3-HYDROXYPROPYL)BENZOATE CODEXIS, INC. (US) 2012-07-19 — — US disclosed
US-20120184000-A1 KETOREDUCTASE POLYPEPTIDES FOR THE PRODUCTION OF (S,E)-METHYL 2-(3-(3-(2-(7-CHLOROQUINOLIN-2-YL)VINYL)PHENYL)-3-HYDROXYPROPYL)BENZOATE CODEXIS, INC. (US) 2012-07-19 — — US disclosed
US-8088610-B2 Ketoreductases for the production of (S,E)-methyl 2-(3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-hroxypropyl)benzoate CODEXIS, INC. (US) 2012-01-03 — — US disclosed
US-8088610-B2 Ketoreductases for the production of (S,E)-methyl 2-(3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-hroxypropyl)benzoate CODEXIS, INC. (US) 2012-01-03 — — US disclosed
WO-2011121091-A1 EFFICIENT SYNTHESIS FOR THE PREPARATION OF MONTELUKAST AND NOVEL CRYSTALLINE FORM OF INTERMEDIATES THEREIN KRKA, D.D., NOVO MESTO (SI) 2011-10-06 — — WO disclosed
WO-2011121091-A1 EFFICIENT SYNTHESIS FOR THE PREPARATION OF MONTELUKAST AND NOVEL CRYSTALLINE FORM OF INTERMEDIATES THEREIN KRKA, D.D., NOVO MESTO (SI) 2011-10-06 — — WO disclosed
EP-2287154-A1 Efficient synthesis for the preparation of montelukast KRKA, D.D., Novo Mesto (SI) 2011-02-23 — — EP disclosed
US-20080306270-A1 Process for the Preparation of a Leukotriene Antagonist and Intermediates Thereof Esteve Química, S.A. (ES) 2008-12-11 — — US disclosed
US-20070135480-A1 PROCESS FOR MAKING MONTELUKAST AND INTERMEDIATES THEREFOR SYNTHON BV (NL) 2007-06-14 — — US disclosed
US-20070135480-A1 PROCESS FOR MAKING MONTELUKAST AND INTERMEDIATES THEREFOR SYNTHON BV (NL) 2007-06-14 — — US disclosed
US-20070135642-A1 PROCESS FOR MAKING MONTELUKAST AND INTERMEDIATES THEREFOR SYNTHON BV (NL) 2007-06-14 — — US disclosed
US-20070135642-A1 PROCESS FOR MAKING MONTELUKAST AND INTERMEDIATES THEREFOR SYNTHON BV (NL) 2007-06-14 — — US disclosed
US-20070135643-A1 PROCESS FOR MAKING MONTELUKAST AND INTERMEDIATES THEREFOR SYNTHON BV (NL) 2007-06-14 — — US disclosed
US-20070135643-A1 PROCESS FOR MAKING MONTELUKAST AND INTERMEDIATES THEREFOR SYNTHON BV (NL) 2007-06-14 — — US disclosed
WO-2007057227-A1 PROCESS FOR MAKING MONTELUKAST AND INTERMEDIATES THEREFOR SYNTHON B.V. (NL) 2007-05-24 — — WO disclosed
WO-2007057225-A2 PROCESS FOR MAKING MONTELUKAST AND INTERMEDIATES THEREFOR SYNTHON B.V. (NL) 2007-05-24 — — WO disclosed
WO-2007057228-A1 A NEW INTERMEDIATE FOR MAKING MONTELUKAST AND RELATED COMPOUNDS SYNTHON B.V. (NL) 2007-05-24 — — WO disclosed
Send feedback